imatinib mesylate (Sun Pharma Global FZE)
Welcome to the PulseAid listing for the imatinib mesylate drug offered from Sun Pharma Global FZE. This Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sun Pharma Global FZE |
NON-PROPRIETARY NAME: | imatinib mesylate |
SUBSTANCE NAME: | IMATINIB MESYLATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-02-01 |
END MARKETING DATE: | 0000-00-00 |
imatinib mesylate HUMAN PRESCRIPTION DRUG Details:
Item Description | imatinib mesylate from Sun Pharma Global FZE |
LABELER NAME: | Sun Pharma Global FZE |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/1) |
START MARKETING DATE: | 2016-02-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 47335-472_7f760b0e-c989-4521-9f02-45d81f1cae7a |
PRODUCT NDC: | 47335-472 |
APPLICATION NUMBER: | ANDA078340 |
Other IMATINIB MESYLATE Pharmaceutical Manufacturers / Labelers: